Sashida, G., Wang, C., Tomioka, T., Oshima, M., Aoyama, K., Kanai, A., . . . Iwama, A. (2016). The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition. J Exp Med.
Citação norma ChicagoSashida, Goro, et al. "The Loss of Ezh2 Drives the Pathogenesis of Myelofibrosis and Sensitizes Tumor-initiating Cells to Bromodomain Inhibition." J Exp Med 2016.
Citação norma MLASashida, Goro, et al. "The Loss of Ezh2 Drives the Pathogenesis of Myelofibrosis and Sensitizes Tumor-initiating Cells to Bromodomain Inhibition." J Exp Med 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.